Berg

BERG is passionate and committed to making a difference in the lives of patients who suffer from and their families. On this Rare Disease Day, BERG would like to thank the patients, their families and care-givers for support of BERG’s commitment to improve lives of patients with Epidermolysis Bullosa (EB). BERG’s mission is dedicated to mapping the molecular cause of disease through the use of Interrogative Biology platform to identify targets, enable novel drug discovery and improve outcomes in all disease. Learn more about us and our mission at https://www.berghealth.com/about/

https://www.rarediseaseday.org/

About | BERG BERG is a clinical-stage, artificial intelligence-powered biotech leveraging its proprietary platform, Interrogative Biology®, to map disease and revolutionize treatments across oncology, neurology and rare diseases. By taking a Back to Biology™ approach, BERG is able to identify critical biomark...